human
cell
lymphotrop
viru
infect
million
peopl
worldwid
major
infect
individu
asymptomat
carrier
ac
viru
infect
peopl
develop
either
adult
cell
leukemialymphoma
atl
chronic
progress
neurolog
diseas
term
myelopathytrop
spastic
paraparesi
hamtsp
hamtsp
character
perivascular
inflammatori
infiltr
brain
spinal
cord
predomin
cell
high
frequenc
effector
cell
demonstr
peripher
blood
even
higher
frequenc
cerebrospin
fluid
csf
patient
hamtsp
robust
humor
respons
antigen
detect
csf
well
serum
cellular
humor
immun
respons
play
crucial
protect
role
infect
chronic
activ
immun
respons
suggest
underli
pathogenesi
hamtsp
therefor
character
immun
respons
may
provid
evid
immun
dysregul
diseas
progress
hamtsp
patient
may
help
identifi
novel
immunotherapeut
target
diseas
despit
strong
immun
respons
provir
load
significantli
elev
hamtsp
patient
compar
ac
increas
express
particularli
transactiv
viral
gene
encod
tax
induc
express
variou
cellular
gene
includ
receptor
directli
contribut
lymphocyt
activ
hamtsp
patient
novel
gene
basic
leucin
zipper
factor
hbz
encod
minu
strand
provir
genom
identifi
hbz
mrna
ubiquit
express
atl
cell
promot
growth
surviv
leukem
cell
hbz
protein
found
inhibit
taxmedi
viral
gene
transcript
ltr
select
suppress
classic
pathway
previou
vivo
studi
also
demonstr
hbz
express
enhanc
infect
cell
prolifer
lymphoma
furthermor
hbz
mrna
express
detect
hamtsp
patient
correl
provir
load
diseas
sever
sinc
find
suggest
hbz
critic
role
persist
develop
atl
hamtsp
import
defin
hbzspecif
immun
respons
individu
recent
evid
shown
hbz
immunogen
protein
recogn
hbzspecif
ctl
clone
hbzspecif
cell
detect
ac
hamtsp
patient
hbzspecif
ctl
clone
abl
lyse
natur
infect
cell
isol
ac
hamtsp
patient
atl
patient
despit
recent
studi
hbzspecif
cellular
immun
respons
report
humor
immun
respons
hbz
recent
report
luciferas
immunoprecipit
system
lip
highli
sensit
quantit
technolog
could
effici
detect
antigenspecif
antibodi
respons
serum
individu
sinc
lip
assay
detect
antibodi
respons
multipl
antigen
profil
antibodi
respons
use
lip
demonstr
differenti
pattern
antibodi
respons
gag
env
tax
uninfect
subject
well
ac
atl
hamtsp
patient
optim
lip
assay
detect
immunoreact
hbz
first
determin
antibodi
respons
hbz
individu
demograph
characterist
studi
group
summar
tabl
among
jamaican
subject
mean
age
studi
group
vari
year
age
donor
nd
group
year
hamtsp
group
p
major
group
compris
femal
although
proport
femal
group
rang
atl
group
ac
group
p
studi
group
predominantli
africandesc
among
nih
subject
mean
age
studi
group
vari
year
nd
group
year
ac
group
p
proport
femal
group
rang
nd
group
ac
group
p
proport
africandesc
caucasiandesc
equal
nd
ac
group
slightli
individu
africandesc
hamtsp
group
antibodi
respons
hbz
analyz
separ
group
jamaican
nih
subject
signific
differ
frequenc
magnitud
antihbz
antibodi
respons
serumplasma
jamaican
nih
subject
data
shown
combin
remain
analys
yield
total
serumplasma
sampl
obtain
nd
ac
atl
patient
hamtsp
patient
strong
mean
antibodi
level
hbz
detect
group
includ
ac
atl
patient
hamtsp
patient
compar
nd
group
figur
tabl
although
mean
antibodi
level
hbz
among
atl
subject
differ
significantli
nd
group
differ
mean
antibodi
level
statist
signific
ac
hamtsp
group
rel
nd
group
figur
within
group
robust
antihbz
antibodi
respons
lu
observ
subset
individu
among
group
mean
antihbz
antibodi
level
significantli
differ
figur
data
analyz
percent
posit
respond
neg
threshold
lu
dot
line
figur
immunoreact
hbz
detect
ac
atl
patient
hamtsp
patient
figur
tabl
frequenc
immunoreact
group
significantli
higher
nd
group
statist
signific
differ
group
figur
addit
fourway
analysi
varianc
anova
model
interact
use
race
gender
age
studi
group
factor
show
signific
differ
level
immunoreact
hbz
gender
race
age
studi
group
data
shown
also
signific
differ
frequenc
immunoreact
hbz
gender
race
age
studi
group
data
shown
sinc
hbz
suggest
play
role
atl
atl
patient
divid
predomin
clinic
uniqu
subtyp
acut
chronic
lymphoma
interest
determin
serum
antihbz
respons
could
discrimin
among
subtyp
mean
antihbz
antibodi
level
significantli
differ
among
atl
subtyp
figur
howev
preval
hbz
immunoreact
detect
atl
patient
acut
subtyp
chronic
subtyp
lymphoma
subtyp
demonstr
atl
patient
chronic
subtyp
show
significantli
higher
antihbz
preval
compar
atl
patient
lymphoma
subtyp
figur
tabl
collect
result
demonstr
individu
without
htlvrelat
diseas
immunoreact
hbz
sinc
hbzspecif
immunoreact
detect
subset
infect
subject
ask
whether
relationship
hbzspecif
immunoreact
immunolog
virolog
marker
infect
antibodi
respons
protein
viral
gene
express
antibodi
respons
gag
env
tax
differ
significantli
individu
without
hbzspecif
immunoreact
figur
also
compar
provir
load
hbz
mrna
express
individu
without
hbzspecif
immunoreact
sinc
pbmc
unavail
jamaican
subject
cell
obtain
nih
hamtsp
patient
whose
serum
test
antihbz
antibodi
respons
hamtsp
patient
show
rang
provir
load
pbmc
figur
consist
previou
report
hbz
mrna
detect
pbmc
hamtsp
patient
significantli
correl
provir
load
figur
signific
differ
provir
load
individu
without
hbzspecif
immunoreact
figur
also
signific
correl
provir
load
hbzspecif
antibodi
respons
figur
moreov
mean
express
hbz
mrna
hamtsp
patient
pbmc
associ
detect
hbz
immunoreact
figur
magnitud
serum
antihbz
antibodi
figur
thu
antibodi
respons
hbz
correl
provir
load
hbz
mrna
express
hamtsp
patient
consist
previou
studi
also
fail
demonstr
correl
hbz
mrna
express
antibodi
titer
serum
sinc
strong
antibodi
respons
antigen
report
serum
csf
hamtsp
patient
also
examin
antibodi
respons
gag
env
tax
hbz
serum
csf
sampl
hamtsp
patient
without
hbzspecif
antibodi
respons
antibodi
respons
gag
env
tax
detect
serum
csf
sampl
five
hamtsp
patient
figur
antibodi
respons
hbz
detect
csf
sampl
hamtsp
patient
hbzspecif
antibodi
respons
serum
hamtsp
patient
neg
hbzspecif
immunoreact
serum
figur
moreov
hbzspecif
antibodi
respons
csf
detect
lower
level
compar
serum
figur
comparison
antibodi
respons
csf
serum
reveal
ratio
antihbz
antibodi
csf
serum
lower
ratio
antigag
antienv
antitax
csf
serum
figur
sinc
hbz
involv
regul
viral
gene
transcript
tcell
prolifer
ask
whether
hbzspecif
antibodi
respons
potenti
benefici
role
suppress
immun
activ
hamtsp
patient
confirm
inhibitori
effect
hbzspecif
antibodi
cell
activ
attempt
gener
immort
memori
b
cell
produc
hbzspecif
antibodi
hamtsp
patient
isol
specif
antibodi
b
cell
cultur
supernat
product
hbzspecif
antibodi
detect
immort
memori
b
cell
cultur
three
hamtsp
patient
hbzspecif
antibodi
respons
figur
control
htlvispecif
antibodi
gag
env
tax
also
abl
detect
memori
b
cell
pool
hamtsp
patient
without
hbzspecif
antibodi
respons
hbzspecif
antibodi
product
detect
memori
b
cell
cultur
hamtsp
patient
without
hbzspecif
antibodi
respons
data
shown
confirm
reactiv
hbzspecif
antibodi
produc
memori
b
cell
examin
hbz
protein
detect
use
antihbz
b
cell
cultur
supernat
western
blot
nuclear
protein
extract
jurkat
infect
cell
line
transfect
cell
shown
figur
bi
hbz
protein
kda
hbzrenilla
luciferas
ruc
fusion
protein
kda
detect
nuclear
protein
extract
infect
cell
line
transfect
cell
respect
use
antihbz
b
cell
cultur
supernat
rabbit
antihbz
serum
use
posit
control
also
react
hbz
protein
hbzruc
fusion
protein
similar
antihbz
b
cell
cultur
supernat
figur
bi
ii
furthermor
isol
hbzspecif
igg
supernat
memori
b
cell
cultur
hamtsp
patient
examin
inhibitori
effect
spontan
lymphoprolifer
pbmc
hamtsp
patient
without
antihbz
respons
repres
dot
plot
show
inhibit
spontan
prolifer
hbzspecif
igg
pbmc
hamtsp
patient
without
antihbz
respons
figur
shown
figur
di
hbzspecif
igg
significantli
inhibit
spontan
lymphoprolifer
predominantli
cell
hamtsp
patient
without
antihbz
respons
sinc
cell
hamtsp
patient
show
significantli
less
prolifer
cell
difficult
observ
inhibitori
effect
hbzspecif
igg
cell
prolifer
hamtsp
patient
without
antihbz
respons
figur
dii
consist
previou
report
frequenc
cell
higher
hamtsp
patient
without
antihbz
antibodi
respons
nd
hamtsp
patient
antihbz
antibodi
respons
show
significantli
less
cell
compar
patient
without
antihbz
antibodi
respons
figur
ei
also
cell
hamtsp
patient
without
antihbz
antibodi
respons
show
significantli
higher
frequenc
cell
nd
figur
eii
frequenc
cell
less
hamtsp
patient
antihbz
respons
patient
without
antihbz
respons
approach
signific
p
figur
eii
result
demonstr
hbzspecif
antibodi
respons
may
role
suppress
cell
activ
hamtsp
patient
hbz
gene
constitut
express
cell
atl
cell
pbmc
individu
thought
involv
regul
viral
gene
transcript
tcell
prolifer
suggest
hbz
critic
role
infect
develop
diseas
therefor
import
defin
hbzspecif
immun
respons
individu
studi
screen
serumplasma
sampl
jamaica
unit
state
includ
nd
ac
atl
hamtsp
patient
first
defin
humor
immun
respons
hbz
individu
result
demonstr
antibodi
respons
hbz
detect
individu
frequenc
antibodi
respons
hbz
low
compar
high
frequenc
antibodi
respons
gag
env
tax
respect
previous
describ
recent
report
hbzspecif
cell
detect
individu
hbzspecif
ctl
clone
abl
lyse
natur
infect
cell
likewis
demonstr
predict
bind
affin
hla
molecul
hbz
peptid
significantli
weaker
tax
peptid
frequenc
hbzspecif
cell
significantli
lower
frequenc
taxspecif
cell
result
support
previou
report
suggest
hbz
immunogen
protein
although
hbzspecif
immun
respons
appear
lower
compar
immunodomin
protein
gag
env
tax
moreov
hbzspecif
humor
immun
respons
show
associ
diseas
outcom
ac
atl
patient
hamtsp
patient
could
discrimin
base
differenti
antibodi
respons
gag
env
tax
atl
patient
show
lower
mean
immunoreact
hbz
compar
hamtsp
patient
figur
tabl
consist
previou
report
atl
patient
demonstr
lower
level
antibodi
respons
three
immunodomin
protein
gag
env
tax
compar
hamtsp
patient
may
consequ
global
immunosuppress
state
atl
hamtsp
interestingli
distribut
hbzspecif
antibodi
respons
atl
subtyp
demonstr
immunoreact
hbz
might
differenti
three
clinic
subtyp
atl
patient
among
atl
patient
signific
differ
hbzspecif
antibodi
respons
patient
chronic
lymphoma
subtyp
figur
median
surviv
patient
atl
week
patient
acut
subtyp
surviv
median
week
patient
lymphoma
subtyp
surviv
median
week
patient
chronic
subtyp
surviv
median
week
diagnost
criteria
clinic
classif
chronic
atl
subtyp
includ
absolut
lymphocyt
lymphocytosi
associ
better
prognosi
compar
acut
lymphoma
atl
subtyp
therefor
result
suggest
subset
atl
patient
gener
hbzspecif
immun
respons
low
magnitud
may
delay
diseas
progress
sinc
previou
report
show
signific
differ
antibodi
respons
gag
env
tax
among
atl
subtyp
import
valid
observ
hbz
larger
sampl
atl
patient
includ
less
common
subtyp
smolder
atl
addit
sinc
high
express
hbz
mrna
report
atl
cell
would
interest
correl
antihbz
antibodi
respons
level
hbz
mrna
unfortun
pbmc
atl
patient
studi
avail
analysi
lack
correl
antibodi
respons
hbz
provir
load
hbz
mrna
express
might
partial
result
virolog
properti
hbz
report
hbz
mrna
detect
pbmc
hamtsp
atl
patient
cultur
mainli
remain
retain
nucleu
cytoplasm
primari
atl
cell
line
splice
form
hbz
protein
detect
nuclear
fraction
report
suggest
persist
might
consequ
reduc
hbz
translat
limit
local
hbz
protein
perhap
reduc
exposur
infect
cell
hbzspecif
host
immun
respons
retroviru
infect
human
immunodefici
viru
hiv
regulatori
protein
tat
play
import
role
viral
infect
pathogen
howev
tatspecif
antibodi
respons
detect
small
number
hivinfect
individu
similarli
antibodi
respons
hbz
observ
subset
individu
genet
factor
hla
may
also
play
role
gener
specif
immun
respons
larger
number
individu
hbzspecif
humor
immun
respons
requir
character
humor
immun
respons
hbz
diseas
antibodi
respons
gag
env
tax
elev
serum
csf
hamtsp
patient
figur
consist
previou
report
contrast
hbzspecif
antibodi
respons
detect
csf
hamtsp
patient
coincid
serum
antibodi
respons
hbz
virusspecif
antibodi
csf
either
deriv
blood
leakag
altern
synthes
local
within
cn
interestingli
ratio
hbzspecif
antibodi
respons
csf
serum
lower
compar
ratio
antibodi
respons
gag
env
tax
csf
serum
figur
result
suggest
hbzspecif
antibodi
csf
deriv
blood
antibodi
gag
env
tax
intrathec
synthes
previous
report
intrathec
antivir
antibodi
synthesi
confirm
presenc
antibodi
oligoclon
igg
csf
lack
intrathec
antibodi
respons
hamtsp
correl
higher
provir
load
wors
outcom
futur
interest
examin
relationship
csf
provir
load
presenc
level
antihbz
antibodi
csf
compar
clinic
phenotyp
hamtsp
patient
without
csf
antihbz
antibodi
lastli
confirm
presenc
function
hbzspecif
antibodi
gener
memori
b
cell
produc
hbzspecif
antibodi
hamtsp
patient
antibodi
respons
hbz
sinc
antigenspecif
human
memori
b
cell
circul
low
frequenc
peripher
blood
mani
research
reli
expans
convers
memori
b
cell
antibodysecret
cell
vitro
cultur
develop
altern
strategi
present
studi
hbzspecif
antibodi
product
detect
memori
b
cell
gener
hamtsp
patient
antibodi
respons
hbz
serum
control
hbzspecif
antibodi
product
detect
memori
b
cell
cultur
gener
hamtsp
patient
without
hbzspecif
antibodi
respons
memori
b
cell
gener
hamtsp
patient
without
hbzspecif
antibodi
respons
could
produc
antibodi
specif
htlvi
gag
env
tax
data
shown
result
suggest
memori
b
cell
maintain
individu
lifetim
level
correl
sustain
serum
antibodi
concentr
moreov
hbzspecif
antibodi
could
significantli
inhibit
spontan
lymphoprolifer
hamtsp
patient
without
antihbz
respons
includ
cell
prolifer
predominantli
infect
cell
cell
also
shown
carri
high
provir
load
hamtsp
patient
hbz
mrna
detect
cell
isol
hamtsp
patient
data
shown
remain
defin
hbzspecif
antibodi
inhibit
cell
prolifer
hamtsp
patient
howev
sinc
humor
immun
limit
extracellular
viral
recognit
neutral
viru
even
within
cytosol
infect
cell
hbzspecif
antibodi
might
therefor
abl
interact
hbz
within
htlvi
infect
cell
experi
includ
nuclear
retent
translat
hbz
mrna
involv
hbz
lymphoprolifer
hamtsp
patient
would
support
conclus
although
detect
inhibitori
effect
hbzspecif
antibodi
cell
prolifer
subset
exhibit
less
spontan
prolifer
cell
presenc
antibodi
respons
hbz
associ
less
cell
activ
frequenc
cell
subset
hamtsp
patient
antihbz
antibodi
respons
cell
frequenc
cell
also
less
hamtsp
patient
antihbz
antibodi
respons
approach
statist
signific
result
demonstr
hbzspecif
antibodi
respons
potenti
benefici
role
suppress
cell
activ
hamtsp
patient
sinc
cell
activ
regul
intric
molecular
immunolog
signal
network
interest
determin
hbzspecif
antibodi
suppress
cell
activ
hamtsp
patient
summari
first
report
demonstr
presenc
humor
immun
respons
hbz
context
character
immun
respons
viral
antigen
improv
knowledg
virushost
interact
pathogenesi
disord
subject
present
analysi
particip
research
studi
conduct
nation
institut
neurolog
disord
stroke
nind
nih
univers
west
indi
uwi
kingston
jamaica
collabor
nation
cancer
institut
nci
bethesda
md
inform
consent
written
obtain
subject
accord
declar
helsinki
nih
subject
serum
sampl
obtain
total
subject
includ
donor
nd
ac
hamtsp
patient
csf
sampl
obtain
hamtsp
patient
studi
review
approv
nation
institut
neurolog
disord
stroke
institut
review
board
jamaican
subject
serum
plasma
sampl
studi
subject
previous
test
htlv
elisa
dupont
wilmington
de
eia
vironostika
organo
teknika
durham
nc
seroposit
sampl
previous
test
western
blot
cambridg
biotech
rockvil
md
genelab
diagnost
blot
singapor
serumplasma
sampl
obtain
total
subject
includ
nd
seroposit
ac
atl
patient
hamtsp
patient
nd
ac
select
particip
nest
studi
risk
factor
seroposit
conduct
among
foodhandl
kingston
clarendon
parish
sampl
subject
obtain
either
studi
previou
seropreval
studi
subject
particip
atl
subject
select
among
atl
case
identifi
islandwid
diseas
registri
refer
uwi
clinic
current
analysi
randomli
select
subject
two
atl
subtyp
acut
lymphoma
subject
atl
subtyp
chronic
total
subject
jamaica
acut
atl
common
subtyp
account
atl
patient
lymphoma
chronic
subtyp
occur
atl
patient
respect
fourth
subtyp
smolder
atl
uncommon
occur
jamaican
atl
patient
includ
analysi
hamtsp
subject
select
among
particip
islandwid
registri
conduct
studi
protocol
follow
human
experiment
guidelin
us
depart
health
human
servic
institut
review
board
approv
nci
uwi
cdna
clone
gag
env
tax
insert
mammalian
renilla
luciferas
express
vector
gener
previous
describ
cdna
clone
hbz
splice
form
kindli
gift
dr
genoveffa
franchini
nci
nih
bethesda
md
primer
use
gener
hbzlipsf
gga
tcc
gcg
gcc
tca
ggg
ctg
ttt
cga
hbzlipsr
tct
aga
tta
ttg
caa
cca
cat
cgc
ctc
mammalian
express
vector
gene
transfect
cell
use
transfect
reagent
roch
diagnost
indianapoli
lip
assay
perform
previous
describ
serum
plasma
csf
sampl
dilut
antihbz
data
independ
experi
normal
use
lu
valu
posit
control
rabbit
antihbz
serum
cutoff
valu
antihbz
immunoreact
defin
hbzlip
antibodi
respons
percentil
valu
nd
group
lu
antigag
antienv
antitax
data
independ
experi
normal
use
lu
valu
posit
control
serum
wellknown
hamtsp
patient
provir
dna
load
measur
use
realtim
pcr
system
appli
biosystem
carlsbad
ca
previous
describ
dna
extract
pbmc
hamtsp
patient
use
qiaamp
dna
blood
mini
kit
qiagen
germantown
md
sampl
dna
solut
per
well
analyz
system
sampl
perform
triplic
total
rna
extract
pbmc
hamtsp
patient
mini
kit
qiagen
accord
manufactur
instruct
ng
total
rna
use
convert
cdna
amplifi
one
step
reaction
use
kit
appli
biosystem
accord
manufactur
instruct
sequenc
primer
probe
hbz
mrna
detect
follow
forward
acg
cga
ctc
aac
revers
cac
agg
caa
gca
tcg
probe
atg
gcg
gcc
tca
ggg
probe
hbz
surround
splice
junction
site
hbz
mrna
method
detect
splice
form
hbz
hypoxanthineguanin
phosphoribosyltransferas
hprt
detect
endogen
control
cell
line
use
calibr
sampl
level
hbz
mrna
express
calcul
use
compar
ct
method
softwar
appli
biosystem
igg
memori
b
cell
isol
pbmc
use
igg
memori
b
cell
isol
kit
miltenyi
bergisch
gladbach
germani
memori
b
cell
seed
cell
per
well
ubottom
micropl
complet
medium
contain
ng
odn
invivogen
san
diego
ca
presenc
ebv
supernat
cell
irradi
allogen
mononuclear
cell
per
well
cultur
two
week
product
antibodi
screen
cultur
supernat
immort
memori
b
cell
use
lip
assay
cultur
supernat
memori
b
cell
produc
antihbz
collect
store
use
desalt
hbzspecif
igg
isol
use
hitrap
protein
g
column
ge
healthcar
uppsala
sweden
concentr
ultra
centrifug
filter
millipor
ireland
product
hbzspecif
antibodi
memori
b
cell
cultur
determin
western
blot
nuclear
protein
extract
uninfect
cell
line
jurkat
cell
cell
use
nuclear
extract
kit
activ
motif
carlsbad
ca
protein
concentr
determin
use
quick
start
bradford
protein
assay
biorad
hercul
ca
protein
sampl
electrophores
gel
invitrogen
gel
transfer
nitrocelluros
membran
invitrogen
block
bsa
tb
membran
probe
b
cell
cultur
supernat
rabbit
antihbz
serum
posit
control
probe
horseradish
peroxidaseconjug
goat
antihuman
igg
santa
cruz
biotechnolog
santa
cruz
ca
membran
visual
chemiluminesc
use
west
pico
chemiluminesc
substrat
thermo
scientif
rockford
il
analyz
profil
kodak
digit
imag
analysi
softwar
kodak
rochest
ny
intens
hbz
protein
detect
b
cell
cultur
supernat
rabbit
antihbz
serum
normal
intens
analysi
peripher
blood
lymphocyt
popul
patient
pbmc
stain
bd
bioscienc
san
jose
ca
flow
cytometr
analysi
perform
use
lsr
ii
bd
bioscienc
data
analyz
use
flowjo
softwar
tree
star
san
carlo
ca
pbmc
label
cfse
cfse
cell
prolifer
kit
invitrogen
accord
manufactur
instruct
plate
cellswel
ubottom
micropl
hbzspecif
igg
human
igg
control
cultur
day
cell
stain
antibodi
bd
bioscienc
data
acquir
lsrii
flow
cytomet
bd
bioscienc
race
gender
age
inform
patient
organ
matrix
form
antihbz
data
gener
patient
use
prism
graphpad
softwar
test
use
compar
age
distribut
among
group
antihbz
antibodi
level
patient
studi
group
ie
nd
ac
atl
hamtsp
antihbz
antibodi
level
atl
subtyp
ie
acut
chronic
lymphoma
antigag
antienv
antitax
antibodi
level
antihbz
posit
antihbz
neg
group
provir
dna
load
hbz
mrna
express
antihbz
posit
antihbz
neg
group
frequenc
cell
nd
hamtsp
patient
without
antibodi
respons
hbz
still
within
prism
chisquar
test
use
compar
gender
racial
distribut
among
group
number
antihbz
posit
antihbz
neg
subject
studi
group
separ
compar
number
antihbz
posit
antihbz
neg
patient
atl
subtyp
prism
wilcoxson
matchedpair
sign
rank
test
use
evalu
inhibitori
effect
hbzspecif
antibodi
spontan
lymphoprolifer
pbmc
hamtsp
patient
lastli
prism
spearman
correl
use
evalu
associ
antihbz
antibodi
level
provir
dna
load
associ
antihbz
antibodi
level
hbz
mrna
express
use
statist
program
languag
r
http
wwwrprojectorg
antihbz
data
log
base
transform
fit
via
fourway
analysi
varianc
anova
model
interact
use
race
gender
age
patient
studi
group
factor
per
race
patient
code
caucasiandesc
africandesc
per
gender
subject
code
male
femal
per
age
subject
code
quartil
young
young
middleag
middleag
senior
senior
posthoc
test
accomplish
use
tukey
honest
signific
differ
method
author
declar
compet
financi
interest
view
express
author
necessarili
us
depart
health
human
servic
nih
fda
dr
maloney
contribut
deriv
former
affili
nation
cancer
institut
current
affili
food
drug
administr
yea
perform
experiment
work
statist
analysi
contribut
paper
write
aa
perform
experiment
work
contribut
paper
write
rm
coordin
clinic
work
analyz
gene
express
contribut
discuss
paper
write
ib
gener
plasmid
contribut
paper
write
krj
perform
statist
analysi
contribut
paper
write
plg
provid
rabbit
antihbz
sera
contribut
paper
write
emm
coordin
identif
subject
analysi
arrang
select
serumplasma
sampl
contribut
discuss
paper
write
sj
supervis
project
contribut
discuss
write
author
read
approv
final
manuscript
